20-36548178-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_006097.5(MYL9):c.331G>A(p.Asp111Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,459,524 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006097.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYL9 | NM_006097.5 | c.331G>A | p.Asp111Asn | missense_variant | 3/4 | ENST00000279022.7 | NP_006088.2 | |
MYL9 | NM_181526.3 | c.185-899G>A | intron_variant | NP_852667.1 | ||||
DLGAP4-AS1 | NR_109939.1 | n.467+23263C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYL9 | ENST00000279022.7 | c.331G>A | p.Asp111Asn | missense_variant | 3/4 | 1 | NM_006097.5 | ENSP00000279022.2 | ||
MYL9 | ENST00000346786.2 | c.185-899G>A | intron_variant | 1 | ENSP00000217313.2 | |||||
DLGAP4-AS1 | ENST00000439595.5 | n.467+23263C>T | intron_variant | 1 | ||||||
DLGAP4-AS1 | ENST00000425233.6 | n.580-20254C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1459524Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 725984
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 15, 2024 | The c.331G>A (p.D111N) alteration is located in exon 3 (coding exon 2) of the MYL9 gene. This alteration results from a G to A substitution at nucleotide position 331, causing the aspartic acid (D) at amino acid position 111 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at